Clinical value of 99Tcm-MIBl SPECT-CT image fusion technology for diagnosing breast tumor and detecting axillary lymph node metastasis
10.3760/cma.j.issn.1006-9801.2009.07.008
- VernacularTitle:99Tcm-MIBI SPECT-CT同机图像融合技术在乳腺肿瘤显像及淋巴结转移判断中的应用
- Author:
Minghui DING
;
Hongyan CUI
;
Jiong LIU
;
Baoniu ZHANG
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Technetium-99Tcm-sestamibi;
Ridionuclide imaging;
Positron-emission tomography;
Image processing,computer assisted
- From:
Cancer Research and Clinic
2009;21(7):455-457
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of 99Tcm-MIBI SPECT-CT image fusion technology for diagnosing breast tumor and detecting axiiiary lymph node metastasis. Methods 99Tcm-MiBI breast and axillary lymph node planar and SPECT-CT imaging in 80 female breast tumor patients were done. All patients had pathological examination results after surgery as control. Results SPECT-CT fusion images sensitivity for breast cancer diagnosis, specificity and accuracy rates were 88.2 % (45/51), 93.1% (26/29) and 90 % (71/80). Planar imaging sensitivity, specificity and accuracy rate were 82.4 % (42/51), 79.3 %(23/29) and 81.3 %(65/80). SPECT-CT fusion images were higher than planar imaging (P <0.05). SPECT-CT fusion images sensitivity, specificity and accuracy for detecting axillary lymph node metastasis were 81.8 %(18/22), 89.7 % (26/29) and 86.3 % (44/51). Planar imaging sensitivity, specificity and accuracy were 77.2 % (17/22), 86.2 % (25/29) and 82.4 %(42/51). There was no significant difference between them (P0.05). Conclusion SPECT-CT image fusion technology in the diagnosis of breast cancer is better than planar imaging. SPECT-CT image fusion in detecting axillary lymph node metastasis of breast cancer is similar to planar imaging.
